- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
回落整理中且下跌有加速趋势。
- 长期趋势：
已有807家主力机构披露2025-06-30报告期持股数据，持仓量总计20.41亿股，占流通A股67.20%
- 波段诊断：
-
技术面诊股
诊断结果：4.6技术面打败了31%的股票
技术面评分前10的股票
近期的平均成本为24.34元。多头行情中，目前处于回落整理阶段且下跌有加速趋势。
平均成本
近期的平均成本为24.34元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"24.34","date":1764230238,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，接近行业平均水平。
[{"date":"2025.11.28","stock":"0.74","trade":"-0.17","ind":"0.85"},{"date":"2025.11.27","stock":"1.09","trade":"-0.20","ind":"-0.25"},{"date":"2025.11.26","stock":"-0.46","trade":"1.10","ind":"1.02"},{"date":"2025.11.25","stock":"0.84","trade":"2.23","ind":"1.53"},{"date":"2025.11.24","stock":"-1.41","trade":"1.45","ind":"0.37"},{"date":"2025.11.21","stock":"-2.54","trade":"-3.83","ind":"-3.41"},{"date":"2025.11.20","stock":"-0.36","trade":"-0.26","ind":"-0.76"},{"date":"2025.11.19","stock":"0.44","trade":"-1.93","ind":"-0.00"},{"date":"2025.11.18","stock":"-1.16","trade":"-1.16","ind":"-0.92"},{"date":"2025.11.17","stock":"-1.45","trade":"-1.58","ind":"-0.11"},{"date":"2025.11.14","stock":"-2.26","trade":"0.97","ind":"-1.93"},{"date":"2025.11.13","stock":"2.76","trade":"1.58","ind":"1.78"},{"date":"2025.11.12","stock":"-0.63","trade":"0.46","ind":"-0.36"},{"date":"2025.11.11","stock":"-1.43","trade":"0.64","ind":"-1.03"},{"date":"2025.11.10","stock":"0.82","trade":"1.26","ind":"0.18"},{"date":"2025.11.07","stock":"4.90","trade":"-0.31","ind":"-0.36"},{"date":"2025.11.06","stock":"1.96","trade":"-0.47","ind":"1.73"},{"date":"2025.11.05","stock":"-0.99","trade":"0.13","ind":"0.37"},{"date":"2025.11.04","stock":"-0.82","trade":"-1.91","ind":"-1.71"},{"date":"2025.11.03","stock":"0.58","trade":"0.77","ind":"0.19"},{"date":"2025.10.31","stock":"0.04","trade":"3.64","ind":"-1.14"}]
新和成,深证成指,化学制药指数
压力支撑
该股压力位为24.37元，支撑位为24.12元。
[{"text":"\u538b\u529b\u4f4d","value":"24.37","date":1764259200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"24.12","date":1764259200,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌有加速趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.0资金面打败了17%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体无进出。
更新时间：11月28日 20:31
| 机构今日流向(万元) | -982.56 | 机构5日流向(万元) | -1333.02 |
| 机构10日流向(万元) | -13343.01 | 机构20日流向(万元) | -18833.13 |
机构持仓
2025-06-30 与 2024-12-31 相比，主力机构持仓量增加2811.42万股，其中基金净减仓158家，主力净增仓130家，请投资者中长期谨慎为宜。
截止2025-06-30，共807家主力机构（基金801家，一般法人3家，社保基金1家，QFII1家，信托公司1家），持仓量总计204064.87万股，占流通A股67.20%
其中，基金持仓与2024-12-31相比：
增仓：137家 ，增持 1451.14万股
减仓：295家 ，减持 2361.86万股
新出现在主力名单中：333家 ，持有4603.95万股
从主力名单中消失：203家 ，原持有5289.56万股
其中，基金持仓与2024-12-31相比：
增仓：137家 ，增持 1451.14万股
减仓：295家 ，减持 2361.86万股
新出现在主力名单中：333家 ，持有4603.95万股
从主力名单中消失：203家 ，原持有5289.56万股
消息面诊股
诊断结果：5.9消息面打败了11%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 新和成：11月25日获融资买入3000.19万元
2025-11-26 - 中国银河证券：化工业供需双底基本确立 2026年或
2025-11-25 - 【开源化工】化工行业2026年年度策略：“反内卷”
2025-11-25 - 新和成获18家机构调研：公司固体蛋氨酸现有产能30
2025-11-24 - 新和成：公司致力于成为新材料行业的生力军
2025-11-24 - 新和成：目前公司香精香料板块主要生产芳樟醇系列等多
2025-11-24 - 新和成：年产45吨全氟己基辛烷、15吨全氟丁基戊烷
2025-11-24 - 新和成：公司布局草铵膦项目主要考虑产业链的协同性
2025-11-24 - 新和成：天津尼龙新材料项目已于2025年9月正式启
2025-11-24 - 新和成：截至10月31日，已回购公司股份2008.
2025-11-24
消息列表
| 一般消息 | 重大事项 | 关联交易 | 2025-10-29 |
| 一般消息 | 股东大会 | 临时股东大会 | 2025-08-28 |
| 利好 | 分红转增 | 10派2元(含税) | 2025-08-28 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-07-02 |
| 一般消息 | 募资投向 | 公司购买资产 | 2025-06-14 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-04-15 |
| 利好 | 分红转增 | 10派5元(含税) | 2025-04-15 |
| 一般消息 | 募资投向 | 2025-04-15 | |
| 一般消息 | 募资投向 | 公司出售资产 | 2025-04-15 |
| 一般消息 | 重大事项 | 关联交易 | 2025-04-15 |
| 重大利好 | 业绩预告 | 业绩大幅上升 | 2025-01-22 |
| 利好 | 分红转增 | 10派2元(含税) | 2024-12-19 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 6条 | 3条 | 3条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：5.5行业面打败了73%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势不明显，跑输大盘。
[{"date":"2025.11.28","price":"0.85","value":"-0.17"},{"date":"2025.11.27","price":"-0.25","value":"-0.20"},{"date":"2025.11.26","price":"1.02","value":"1.10"},{"date":"2025.11.25","price":"1.53","value":"2.23"},{"date":"2025.11.24","price":"0.37","value":"1.45"},{"date":"2025.11.21","price":"-3.41","value":"-3.83"},{"date":"2025.11.20","price":"-0.76","value":"-0.26"},{"date":"2025.11.19","price":"-0.00","value":"-1.93"},{"date":"2025.11.18","price":"-0.92","value":"-1.16"},{"date":"2025.11.17","price":"-0.11","value":"-1.58"},{"date":"2025.11.14","price":"-1.93","value":"0.97"},{"date":"2025.11.13","price":"1.78","value":"1.58"},{"date":"2025.11.12","price":"-0.36","value":"0.46"},{"date":"2025.11.11","price":"-1.03","value":"0.64"},{"date":"2025.11.10","price":"0.18","value":"1.26"},{"date":"2025.11.07","price":"-0.36","value":"-0.31"},{"date":"2025.11.06","price":"1.73","value":"-0.47"},{"date":"2025.11.05","price":"0.37","value":"0.13"},{"date":"2025.11.04","price":"-1.71","value":"-1.91"},{"date":"2025.11.03","price":"0.19","value":"0.77"},{"date":"2025.10.31","price":"-1.14","value":"3.64"}]
深证成指,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 富祥药业 | 55.13% | 3.72% | 4.4分 |
| 2 | 康芝药业 | 45.54% | 9.47% | 6.0分 |
| 3 | 海南海药 | 35.62% | -0.95% | 5.9分 |
| 4 | 广济药业 | 35.16% | 31.74% | 6.0分 |
| 5 | *ST苏吴 | 29.17% | 27.84% | 5.8分 |
| 6 | 前沿生物 | 26.29% | 23.12% | 6.3分 |
| 8 | *ST景峰 | 19.97% | 3.54% | 5.5分 |
| 10 | 悦康药业 | 14.21% | 14.06% | 6.5分 |
| 12 | 亨迪药业 | 11.45% | 8.89% | 5.6分 |
| 14 | 新华制药 | 10.92% | 13.80% | 5.5分 |
| 16 | 赛分科技 | 8.82% | 5.76% | 5.6分 |
| 18 | 福元医药 | 7.98% | 13.13% | 5.7分 |
| 20 | 泽璟制药 | 5.89% | 8.67% | 6.6分 |
| 22 | 海思科 | 5.60% | 6.46% | 7.0分 |
| 24 | 京新药业 | 5.20% | -3.32% | 6.2分 |
| 26 | 润都股份 | 4.68% | 5.15% | 5.9分 |
| 28 | 山河药辅 | 4.24% | 6.14% | 5.6分 |
| 30 | 双鹭药业 | 3.58% | 7.12% | 5.3分 |
| 32 | 华仁药业 | 3.24% | 7.01% | 5.7分 |
| 34 | 普洛药业 | 2.96% | 1.01% | 6.5分 |
| 36 | 津药药业 | 2.60% | 2.84% | 5.6分 |
| 38 | 必贝特 | 2.14% | 22.04% | 5.9分 |
| 40 | *ST赛隆 | 2.08% | 9.39% | 5.6分 |
| 42 | 健康元 | 1.56% | 3.26% | 5.5分 |
| 44 | 首药控股 | 1.39% | 4.45% | 5.7分 |
| 46 | 迪哲医药 | 1.26% | 3.73% | 5.9分 |
| 48 | 华东医药 | 1.01% | 4.06% | 5.7分 |
| 50 | 东北制药 | 0.72% | 3.90% | 5.4分 |
| 52 | 哈三联 | 0.57% | 9.23% | 4.5分 |
| 54 | 新和成 | 0.33% | 0.79% | 5.2分 |
| 56 | 莎普爱思 | 0.12% | 5.12% | 5.4分 |
| 58 | *ST三圣 | -0.20% | 4.96% | 4.3分 |
| 60 | 威尔药业 | -0.31% | 6.74% | 5.6分 |
| 62 | 圣诺生物 | -0.92% | 7.64% | 6.5分 |
| 64 | 西点药业 | -0.97% | 3.90% | 5.3分 |
| 66 | 立方制药 | -1.10% | 1.64% | 5.1分 |
| 68 | 国药现代 | -1.25% | 1.08% | 5.4分 |
| 70 | 哈药股份 | -1.64% | 1.98% | 5.3分 |
| 72 | ST复华 | -1.70% | 4.72% | 4.5分 |
| 74 | 鲁抗医药 | -2.00% | 5.03% | 5.2分 |
| 76 | 仙琚制药 | -2.11% | -0.86% | 4.7分 |
| 78 | 百济神州 | -2.38% | 3.88% | 5.3分 |
| 80 | ST诺泰 | -2.60% | 0.85% | 4.8分 |
| 82 | 益方生物 | -2.71% | 15.74% | 6.0分 |
| 84 | 恩华药业 | -3.22% | 2.87% | 4.8分 |
| 86 | 丽珠集团 | -3.24% | 0.17% | 5.1分 |
| 88 | 华润双鹤 | -3.37% | 0.54% | 5.4分 |
| 90 | 健友股份 | -3.49% | -1.52% | 4.8分 |
| 92 | 宏源药业 | -3.62% | 4.72% | 3.8分 |
| 94 | 金城医药 | -3.71% | 4.92% | 4.8分 |
| 96 | 宣泰医药 | -4.37% | 3.86% | 5.3分 |
| 98 | 誉衡药业 | -5.00% | 3.86% | 5.6分 |
| 100 | 德展健康 | -5.02% | 1.22% | 3.9分 |
| 102 | 新天地 | -5.61% | 2.38% | 5.2分 |
| 104 | 永安药业 | -5.72% | 3.29% | 4.8分 |
| 106 | 华海药业 | -6.10% | 7.20% | 5.6分 |
| 108 | 富士莱 | -6.30% | 1.98% | 4.9分 |
| 110 | 北陆药业 | -6.43% | 4.28% | 4.9分 |
| 112 | 能特科技 | -6.72% | 2.27% | 5.1分 |
| 114 | 复星医药 | -7.09% | 1.16% | 5.4分 |
| 116 | 汇宇制药 | -7.37% | 6.64% | 5.4分 |
| 118 | - | -7.69% | 0.99% | 分 |
| 120 | 科源制药 | -8.04% | 1.24% | 4.3分 |
| 122 | 川宁生物 | -8.25% | 0.38% | 4.2分 |
| 124 | 海创药业 | -8.44% | 10.66% | 5.6分 |
| 126 | 人福医药 | -8.56% | 0.89% | 5.5分 |
| 128 | 微芯生物 | -9.01% | 4.89% | 5.5分 |
| 130 | 苑东生物 | -9.37% | 4.80% | 5.6分 |
| 132 | 小方制药 | -9.40% | 1.88% | 5.4分 |
| 134 | 键凯科技 | -9.67% | 8.15% | 5.6分 |
| 136 | 海辰药业 | -9.82% | 0.14% | 3.9分 |
| 138 | - | -10.04% | 2.56% | 分 |
| 140 | 上海谊众 | -11.75% | 1.12% | 5.3分 |
| 142 | 纳微科技 | -11.95% | 1.05% | 5.1分 |
| 144 | 翰宇药业 | -12.73% | 3.61% | 5.2分 |
| 146 | 盟科药业 | -13.56% | 2.69% | 4.8分 |
| 148 | 联环药业 | -14.38% | -1.27% | 4.1分 |
| 150 | - | -15.28% | 0.04% | 分 |
| 152 | - | -15.92% | 0.21% | 分 |
| 154 | 向日葵 | -16.04% | 3.68% | 4.4分 |
| 156 | - | -17.17% | -1.31% | 分 |
| 158 | 舒泰神 | -20.89% | -5.08% | 3.8分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-09-30 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 3/219 ， 84/219。
[{"date":"2025-09-30","value":"17.30","vol":"1.46"},{"date":"2025-06-30","value":"12.05","vol":"1.21"},{"date":"2025-03-31","value":"6.27","vol":"-0.17"},{"date":"2024-12-31","value":"21.68","vol":"19.51"},{"date":"2024-09-30","value":"15.27","vol":"4.61"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
17.30 | 12.05 | 6.27 | 21.68 | 15.27 |
| 行业(%) | 1.46 | 1.21 | -0.17 | 19.51 | 4.61 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"45.55","vol":"49.47"},{"date":"2025-06-30","value":"45.89","vol":"49.43"},{"date":"2025-03-31","value":"46.70","vol":"49.23"},{"date":"2024-12-31","value":"41.78","vol":"50.77"},{"date":"2024-09-30","value":"39.54","vol":"50.51"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
45.55 | 45.89 | 46.70 | 41.78 | 39.54 |
| 行业(%) | 49.47 | 49.43 | 49.23 | 50.77 | 50.51 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 43/219 ， 35/219。
[{"date":"2025-09-30","value":"5.45","vol":"141.76"},{"date":"2025-06-30","value":"12.76","vol":"78.53"},{"date":"2025-03-31","value":"20.91","vol":"-0.84"},{"date":"2024-12-31","value":"42.95","vol":"17.76"},{"date":"2024-09-30","value":"43.31","vol":"45.69"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
5.45 | 12.76 | 20.91 | 42.95 | 43.31 |
| 行业(%) | 141.76 | 78.53 | -0.84 | 17.76 | 45.69 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"33.37","vol":"-5.21"},{"date":"2025-06-30","value":"63.46","vol":"56.29"},{"date":"2025-03-31","value":"116.18","vol":"-21.21"},{"date":"2024-12-31","value":"117.01","vol":"-20.55"},{"date":"2024-09-30","value":"89.87","vol":"-32.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
33.37 | 63.46 | 116.18 | 117.01 | 89.87 |
| 行业(%) | -5.21 | 56.29 | -21.21 | -20.55 | -32.33 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 41/219 ， 49/219。
[{"date":"2025-09-30","value":"0.38","vol":"0.31"},{"date":"2025-06-30","value":"0.26","vol":"0.21"},{"date":"2025-03-31","value":"0.13","vol":"0.10"},{"date":"2024-12-31","value":"0.53","vol":"0.43"},{"date":"2024-09-30","value":"0.39","vol":"0.33"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.38 | 0.26 | 0.13 | 0.53 | 0.39 |
| 行业(次) | 0.31 | 0.21 | 0.10 | 0.43 | 0.33 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"2.11","vol":"1.95"},{"date":"2025-06-30","value":"1.39","vol":"1.31"},{"date":"2025-03-31","value":"0.69","vol":"0.67"},{"date":"2024-12-31","value":"2.99","vol":"3.22"},{"date":"2024-09-30","value":"2.42","vol":"2.18"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.11 | 1.39 | 0.69 | 2.99 | 2.42 |
| 行业(次) | 1.95 | 1.31 | 0.67 | 3.22 | 2.18 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-09-30","value":"43.30","vol":"4.36"},{"date":"2025-06-30","value":"29.09","vol":"2.81"},{"date":"2025-03-31","value":"29.34","vol":"-28.76"},{"date":"2024-12-31","value":"42.83","vol":"-371.46"},{"date":"2024-09-30","value":"41.07","vol":"-9.87"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 43.30 | 29.09 | 29.34 | 42.83 | 41.07 |
| 行业 | 4.36 | 2.81 | -28.76 | -371.46 | -9.87 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.55","vol":"1.72"},{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"0.72","vol":"1.99"},{"date":"2024-09-30","value":"","vol":"0.00"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.55 | - | 0.72 | - |
| 行业 | 0.00 | 1.72 | 0.00 | 1.99 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 30/219 ， 85/219。
[{"date":"2025-09-30","value":"2.43","vol":"3.49"},{"date":"2025-06-30","value":"2.38","vol":"3.67"},{"date":"2025-03-31","value":"2.61","vol":"3.59"},{"date":"2024-12-31","value":"2.45","vol":"3.34"},{"date":"2024-09-30","value":"2.53","vol":"3.66"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.43 | 2.38 | 2.61 | 2.45 | 2.53 |
| 行业 | 3.49 | 3.67 | 3.59 | 3.34 | 3.66 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"1.84","vol":"2.74"},{"date":"2025-06-30","value":"1.76","vol":"2.89"},{"date":"2025-03-31","value":"1.95","vol":"2.81"},{"date":"2024-12-31","value":"1.83","vol":"2.64"},{"date":"2024-09-30","value":"1.90","vol":"2.92"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.84 | 1.76 | 1.95 | 1.83 | 1.90 |
| 行业 | 2.74 | 2.89 | 2.81 | 2.64 | 2.92 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 74/219 ， 77/219。
[{"date":"2025-09-30","value":"28.25","vol":"33.75"},{"date":"2025-06-30","value":"29.97","vol":"33.79"},{"date":"2025-03-31","value":"29.74","vol":"34.04"},{"date":"2024-12-31","value":"31.50","vol":"34.19"},{"date":"2024-09-30","value":"33.56","vol":"33.02"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
28.25 | 29.97 | 29.74 | 31.50 | 33.56 |
| 行业(%) | 33.75 | 33.79 | 34.04 | 34.19 | 33.02 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-09-30","value":"0.40","vol":"0.94"},{"date":"2025-06-30","value":"0.43","vol":"0.88"},{"date":"2025-03-31","value":"0.43","vol":"1.46"},{"date":"2024-12-31","value":"0.46","vol":"0.84"},{"date":"2024-09-30","value":"0.51","vol":"0.73"}]
| 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.40 | 0.43 | 0.43 | 0.46 | 0.51 |
| 行业(%) | 0.94 | 0.88 | 1.46 | 0.84 | 0.73 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 华安证券 | 2025-11-17 | 买入 | 买入 |
| 华泰证券 | 2025-11-05 | 增持 | 增持 |
| 长城证券 | 2025-11-04 | 买入 | 买入 |
| 兴业证券 | 2025-11-01 | 增持 | 增持 |
| 华创证券 | 2025-10-31 | 买入 | 买入 |
| 国海证券 | 2025-10-31 | 买入 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"43.56","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"36.20","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"27.04","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"58.69","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"66.06","blueLineValue":"2.15","type":"YC"}]